Stock Rating Downgrade
The Value Trend Rating for Amgen Inc (NASDAQ: AMGN) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Amgen Inc (NASDAQ: AMGN) stock declined modestly by -1.4% on 2/7/25. The stock closed at $293.54. This decline was accompanied by normal trading volume. The stock has risen 3.4% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Amgen has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Amgen has a neutral Appreciation Score of 54 and a slightly negative Power Rating of 30, leading to the Negative Value Trend Rating.
Be the first to comment